Diagnostic method | Description of symptoms |
---|---|
Treatment | Â |
   Burge et al., 2003 [58]b | Chest problem requiring treatment with oral corticosteroids and/or antibiotics as defined by the treating physician |
   Calverley et al., 2003 [59] | Worsening of COPD symptoms that required treatment with antibiotics, oral corticosteroids or both |
   Jones et al., 2003 [60]b | Chest problems requiring treatment with antibiotics and/or oral corticosteroids |
   Andersson et al., 2002 [61] | Increased dose of current treatment and/or treatment with antibiotics or systemic corticosteroids and/or general practitioner or outpatient visit or hospital admission |
   Burge et al., 2000 [62]b | Worsening of respiratory symptoms that required treatment with oral corticosteroids, antibiotics or both as judged by the general practitioner |
Symptoms | Â |
   Effing et al., 2009 [63] | Presence for at least 2 consecutive days of an increase in any two major symptoms or an increase in one major and one minor symptom |
   Worth et al., 2009 [64] | A complex of at least two respiratory adverse events with a duration of more than 3 days |
   Schermer et al., 2009 [65] | Episode with one or more subsequent unscheduled contacts with either a general practitioner or a chest physician because of worsening of respiratory symptoms |
   O'Reilly et al., 2006 [66]c | Symptom-based: Symptom score of at least 2 for 2 consecutive days with no score for at least two of these symptoms in the previous 5 days Healthcare-based: Need to take antibiotics and/or oral corticosteroids for chest problem |
   Wilkinson et al., 2006 [67] | Not defined but specified as symptom-based |
   Donaldson et al., 2003 [68] | An increase in either two or more major symptoms or any one major symptom plus any minor symptoms occurring on 2 or more consecutive days |
   Seemungal et al., 2000 [69] | Presence for at least 2 consecutive days of an increase in any two major symptoms or an increase in one major and one minor symptom |
Treatment and symptoms | Â |
   Seemungal et al., 2008 [70] | Sustained worsening of baseline respiratory symptoms for at least 2 days that required treatment with oral corticosteroids and/or antibiotics |
   Tashkin et al., 2008 [71] | Increase or new onset of more than one respiratory symptom (cough, sputum, sputum purulence, wheezing or dyspnea) lasting 3 days or more and requiring treatment with an antibiotic or a systemic corticosteroid |
   Calverley et al., 2008 [72] | Clinically significant worsening of COPD symptoms requiring treatment with antibiotics and/or systemic steroids |
   Wedzicha et al., 2008 [73] | Symptom worsening that required treatment with oral corticosteroids and/or antibiotics or required hospitalization |
   Dusser et al., 2006 [74] | Onset of at least one clinical descriptor (worsening of dyspnea, cough or sputum production, appearance of purulent sputum, fever (>38°C), appearance of a new chest radiograph abnormality) lasting ≥2 days and requiring a new prescription or an increase in the dose of β2-agonists, antibiotics, corticosteroids or bronchodilators |
   Soler-Cataluña et al., 2005 [55] | Sustained increase in respiratory symptomatology compared with baseline requiring modification of regular medication and hospital treatment (acute exacerbation of COPD) |
   Oostenbrink et al., 2004 [75] | Complex of respiratory symptoms (new onset or worsening of more than one symptom such as cough, sputum, dyspnea or wheeze) lasting for ≥3 days |
   Brusasco et al., 2003 [76] | Complex of respiratory symptoms (new onset or an increase in at least one of the following: cough, sputum, dyspnea, wheeze, chest discomfort) lasting at least 3 days and usually associated with therapeutic intervention |
Model | Â |
   Borg et al., 2004 [77] | Increase in any two major symptoms (dyspnea, sputum purulence, sputum amount) or an increase in one major and one minor symptom (wheeze, sore throat, cough, and symptoms of a common cold, which were nasal congestion and/or discharge) for at least 2 consecutive days |
Not defined | Â |
   Detournay et al., 2004 [53] | ND |